Quantum-Si Customers Showcase Protein Sequencing Breakthroughs at AACR
Event summary
- Two customer posters featuring Quantum-Si’s single-molecule protein sequencing technology will be presented at the AACR annual meeting on April 17-22, 2026.
- Poster 2421 explores combining genetic and proteomic approaches to develop DNA repair inhibitors.
- Poster 7650 demonstrates high-resolution detection of post-translational modifications using Quantum-Si’s technology.
- Quantum-Si aims to expand awareness and build momentum toward the launch of its Proteus™ platform.
The big picture
Quantum-Si’s customer presentations at AACR highlight the growing validation of its single-molecule protein sequencing technology in cancer research. The company is positioning itself as a key player in democratizing advanced protein characterization, which could significantly impact biomarker studies and therapeutic development. The strategic focus on building a pipeline of studies and expanding awareness suggests a push toward broader commercialization and market differentiation.
What we're watching
- Technology Adoption
- How the demonstration of Quantum-Si’s technology at AACR will affect its market penetration and adoption rates.
- Product Launch
- The pace at which Quantum-Si can build momentum toward the launch of its Proteus™ platform following these presentations.
- Competitive Positioning
- Whether Quantum-Si can sustain its competitive edge in the proteomics space with continued customer-driven validation.
Related topics